Furthermore, we identified borussertib, a covalent allosteric inhibitor of SYT4, which selectively suppresses SYT4-driven tumor growth in GC cells and xenograft models by inhibiting the Wnt/β-catenin pathway 11. This evidence concerns the gene SYT4 and gastric cancer.